Miriam MBA - Pharma Bio HR Mang
| PBSV Stock | USD 0.61 0.11 22.00% |
Insider
Miriam MBA is HR Mang of Pharma Bio Serv
| Phone | 787 278 2709 |
| Web | https://www.pharmabioserv.com |
Pharma Bio Management Efficiency
The company has return on total asset (ROA) of 0.033 % which means that it generated a profit of $0.033 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0568 %, meaning that it created $0.0568 on every $100 dollars invested by stockholders. Pharma Bio's management efficiency ratios could be used to measure how well Pharma Bio manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 3 records | INSIDER Age | ||
| Kevin Pitts | Grey Cloak Tech | 63 | |
| Scott Landers | Grey Cloak Tech | N/A | |
| Robert Madden | Grey Cloak Tech | 51 | |
Management Performance
| Return On Equity | 0.0568 | |||
| Return On Asset | 0.033 |
Pharma Bio Serv Leadership Team
Elected by the shareholders, the Pharma Bio's board of directors comprises two types of representatives: Pharma Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pharma. The board's role is to monitor Pharma Bio's management team and ensure that shareholders' interests are well served. Pharma Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pharma Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pedro Lasanta, CFO, VP of Fin. and Admin. and Secretary | ||
| Victor Sanchez, CEO and President and President of European Operations | ||
| Elizabeth Plaza, Founder, Chairman, Sr. Strategic Consultant and Member of Nominating Committee | ||
| Miriam MBA, HR Mang |
Pharma Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Pharma Bio a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0568 | |||
| Return On Asset | 0.033 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 4.87 M | |||
| Shares Outstanding | 22.95 M | |||
| Shares Owned By Insiders | 64.53 % | |||
| Price To Earning | 10.00 X | |||
| Price To Book | 1.15 X | |||
| Price To Sales | 0.90 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Pharma OTC Stock Analysis
When running Pharma Bio's price analysis, check to measure Pharma Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma Bio is operating at the current time. Most of Pharma Bio's value examination focuses on studying past and present price action to predict the probability of Pharma Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma Bio's price. Additionally, you may evaluate how the addition of Pharma Bio to your portfolios can decrease your overall portfolio volatility.